CHRISTOPHER JOHN PITTENGER

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Microglial dysregulation in psychiatric disease
    Luciana Romina Frick
    Department of Psychiatry, Yale University School of Medicine, 34 Park Street, W315, New Haven, CT 06519, USA
    Clin Dev Immunol 2013:608654. 2013
  2. ncbi request reprint Disorders of memory and plasticity in psychiatric disease
    Christopher Pittenger
    Yale OCD Research Clinic, Yale University School of Medicine, New Haven, Connecticut, USA
    Dialogues Clin Neurosci 15:455-63. 2013
  3. ncbi request reprint Riluzole in the treatment of mood and anxiety disorders
    Christopher Pittenger
    Clinical Neuroscience Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 22:761-86. 2008
  4. pmc Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA
    Pharmacol Ther 132:314-32. 2011

Research Grants

Collaborators

Detail Information

Publications5

  1. pmc Microglial dysregulation in psychiatric disease
    Luciana Romina Frick
    Department of Psychiatry, Yale University School of Medicine, 34 Park Street, W315, New Haven, CT 06519, USA
    Clin Dev Immunol 2013:608654. 2013
    ..If microglial pathology proves to be an important causative factor in these or other neuropsychiatric diseases, modulators of microglial function may represent a novel therapeutic strategy...
  2. ncbi request reprint Disorders of memory and plasticity in psychiatric disease
    Christopher Pittenger
    Yale OCD Research Clinic, Yale University School of Medicine, New Haven, Connecticut, USA
    Dialogues Clin Neurosci 15:455-63. 2013
    ....
  3. ncbi request reprint Riluzole in the treatment of mood and anxiety disorders
    Christopher Pittenger
    Clinical Neuroscience Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 22:761-86. 2008
    ..Riluzole may hold promise for the treatment of several psychiatric conditions, possibly through its ability to modulate pathologically dysregulated glutamate levels, and merits further investigation...
  4. pmc Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment
    Christopher Pittenger
    Department of Psychiatry, Yale University School of Medicine, USA
    Pharmacol Ther 132:314-32. 2011
    ....

Research Grants2

  1. Pathophysiologically Realistic Mouse Models of Neuropsychiatric Disease: Tourette
    CHRISTOPHER JOHN PITTENGER; Fiscal Year: 2010
    ..This approach is developed in the specific case of Tourette syndrome;but the principal and many of the technical aspects of our approach are generalizable to the modeling and investigation of other neuropsychiatric conditions. ..